StonvexLoading…
StonvexStonvexStonvexCore line items from CMC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-06-22 | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Annual 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|---|
Revenue | $2.47B | $4.25B | $2.12B | $7.80B | $5.68B |
Operating Income | Not available | $292.68M | $182.94M | $107.55M | $-85.69M |
Net Income | Not available | $270.31M | $177.28M | $84.66M | $-67.12M |
EPS (Diluted) | $1.85 | $2.41 | $1.58 | $0.74 | $-0.59 |
Total Assets | Not available | $9.56B | $9.24B | $7.17B | $6.99B |
Total Liabilities | Not available | $5.16B | $4.93B | $2.98B | $2.90B |
Cash & Equivalents | Not available | $503.63M | $3.03B | $1.05B | $895.13M |
Free Cash Flow OCF − CapEx | Not available | $122.32M | $78.75M | $312.25M | $105.96M |
Shares Outstanding | Not available | 110.97M | 111.01M | 111.19M | 112.16M |